PM360 Featured Articles
The healthcare market is a dynamic market in every aspect. From advances in biotechnology giving rise to genomic therapies to the continuous emergence and consolidation of the companies who operate in this market, healthcare is an evolving industry. It should be no surprise then that the legislative policy and regulatory framework governing the industry is […]
The healthcare environment continues to evolve and one thing is evident. That is, “the good old days” of marketing medical devices to only physicians/clinicians are gone forever. Marketing medical devices in today’s healthcare environment is just about as difficult as it gets. For years, marketing professionals could take the slightest differentiated qualities of a product […]
Every year, marketing departments across our industry invest a great deal of time and money on maximizing their company’s presence at conferences. In fact, exhibiting can account for 41% of a firm’s total marketing spend across all channels, according to EXHIBITOR. It’s an important part of the marketing mix, yet it is frequently the one […]
The face of the American population is changing. It is time for pharma marketers to embrace the new normal. Minorities now account for over one-third (39%) of the total U.S. population, and by 2030, nearly half (45%) of the population will be multicultural. Within this growing market, U.S. Hispanics represent the largest segment at over […]
A patient who used to treat her ailments with over-the-counter (OTC) and home remedies, and took pride in the number of years it had been since she saw her doctor, now researches her condition early and visits her doctor for preventive care. A middle-aged man who has always been aware of the health benefits […]
Panorama Articles
EightSpokes recently introduced Enlighten, the world’s first Enterprise Project Collaboration (EPC) application. Rather than a project management solution, like Microsoft Project, Enlighten is collaboration management designed to facilitate seamless information exchange between cross-functional teams to accelerate drug development and commercialization in life science companies. In fact, beta testers of the software have seen their productivity […]
After spending millions on R&D just to get a product to market—and millions more to promote a product—there is nothing worse than when a launch falls completely flat. Kelly Wilder, Executive Vice President of Precision for Value, and her team have identified several critical mistakes that pharma companies make that can reduce the perceived value […]
Autoimmune diseases affect more than 23.5 million Americans, according to the National Institutes of Health. The prevalence of some of the most common autoimmune and inflammatory disorders, such as rheumatoid arthritis, Hashimoto’s, type 1 diabetes, lupus, multiple sclerosis, Crohn’s, and Sjogren’s, is predicted to increase. The symptoms of autoimmune disorders can be debilitating and make […]
The use of key opinion leaders (KOLs) has been a staple of life sciences business strategy for decades. Commercial and medical teams routinely identify and engage KOLs for research, publishing, and speaking, among other tasks. Patient advocacy teams regularly partner with patient support groups on mutually beneficial projects. Few industry executives question the value of […]
In April, members of the NYC Health Business Leaders (NYCHBL) gathered for a discussion at Outcome Health’s Midtown office to discuss the transforming landscape of patient-provider interactions and how to improve outcomes. NYCHBL President Bunny Ellerin explained, “We wanted to assemble a panel of experts to discuss real-world solutions on how we as healthcare leaders […]
The space in which patients and HCPs navigate while making treatment decisions is complex and intertwined. Yet, brands often plan patient and HCP marketing efforts in silos. The goal is to encourage positive patient and HCP conversations and the hope is each individual team’s efforts lead to a dialogue. But hope is not a strategy. […]
GTO Greater Good is pleased to announce it has received a grant from the U.S. Mission to UNESCO’s Education office. The grant will allow GTO Greater Good to develop and implement an interactive, dynamic digital teaching platform to help prevent violent extremism. The digital platform is an innovative solution aimed at addressing violent extremism through […]
Pharma Dialogue
My last post raised the 21st Century Human. Essentially, we’re different. Old and young. Millennial and Boomer. Not just from each other (that’s old news) but we’re different because we live in a new cultural code. Want proof? 3 questions: 1. Would we have really cared, on mass, about Cecil (the lion) being killed by […]
Shockingly, we’re different. It’s hard to imagine humans changing as rapidly as we’re seeing, but it’s real. Yes, smartphones have liberated and empowered us. Yes, social networking has liberated and empowered us. But, that’s the enabler. The root is a shift in us, in our reordering of values, motivators and even needs. Having spent 20+ […]
Brand Experience is all of the touch points that drive how a customer experiences your brand. In today’s world that includes user and non-user generated content as much as it includes what you do as a Brand. Brand Experience still matters, but with the emergence of the importance of a brand purpose—the reason your brand/your […]
Have you ever posted a bad review? A negative experience? A glowing endorsement? Of course you have because we’re all content creators and the new critic. Smartphones and social media are our slingshots. And easily accessible. It used to be that you had to take out a pen and paper to voice your feedback or […]
I barely remember the moon landing, but I remember when and where I was when I saw the first iPod and importantly, the emotion I felt when I saw it. It was a jewel of design. Unlike the nasty looking Walkman, the iPod was sleek, stunning in its contrast of metal back and opaque white […]
Conference News
News powered by
View all Conference News- MV disease in children requires modified strategiesMitral Valve Conclave
- T receptor diversity may predict BCP-ALL response to blinatumomabEuropean Hematology Association
- Pembrolizumab + rituximab boost response rates in relapsed follicular lymphoma13th International Conference on Malignant Lymphoma
- IL-6 nanobody vobarilizumab advances despite equivocal phase II dataEULAR Annual Congress
- CARs race for supremacy against aggressive non-Hodgkin lymphomaEuropean Hematology Association
- Biosimilar immunogenicity studies produce no surprisesEULAR Annual Congress
- Biologics, TNF-inhibitors confer no excess cancer risks upon RA patientsEULAR Annual Congress
- Gene editing aims to recreate beneficial mutation in SCD, beta-thalassemiaEuropean Hematology Association
- Oral insulin matches glargine in phase II trialAmerican Diabetes Assn. Annual Scientific Session
- Safety data review finds no increased risk of infection from abataceptEULAR Annual Congress
- Midostaurin improves survival in new AMLEuropean Hematology Association
- Ibrutinib dons new anti-GVHD hatEuropean Hematology Association
- Apremilast eases PsA symptoms in patients who are naive to biologicsEULAR Annual Congress
- Overall survival better in advanced Hodgkin lymphoma with shorter eBEACOPPEuropean Hematology Association
- Major bleeding deaths may outweigh VTE risk in older cancer patientsEuropean Hematology Association
